Novo Nordisk is also discontinuing two insulin detemir solutions — Levemir Flexpen subcutaneous injection, 100 units per milliliter pen; and Levemir subcutaneous injection, 100 units per ...

LONDON (CBS.MW) -- Technip on Tuesday said it won a 128 million euro contract to build an insulin plant in France for Novo Nordisk .

Its long-acting insulin, Levemir, will be lowered to $107.85 per vial and $161.77 per pen, a 65% reduction. Its Novolin prices also will be cut by 65% to $48.20 per vial and $91.09 per pen.

Novo Nordisk says it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical medicine ...

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient groups all counted the move as a win. But several ...

MSF estimates insulin pens can be produced for $0.94 while being profitable; current U.S. price is $90.69. Diabetes affects 537 million globally, with African cases expected to rise by 134% by ...

Ellison sued Novo Nordisk in 2018, alleging the company deceptively overpriced its insulin. In 2024, AG Ellison reached similar settlements with Eli Lilly and Sanofi, two other defendants in the ...

Novo Nordisk A/S has entered into exclusive negotiations for a controlling stake in Biocorp SA, suppliers of Mallya, a Bluetooth-enabled smart add-on device for insulin pen injectors. The takeover ...

South Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority said on Tuesday, 4 ...

The "Insulin Pens Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The insulin pens market is expected to grow at a CAGR of 6.26% during ...

PARIS, FRANCE / ACCESSWIRE / March 21, 2023 / SFD 2023 - Diabeloop, a pioneer in Automated Insulin Delivery, will collaborate with leading global healthcare company, Novo Nordisk.